Discover how evolutionary functional genomics is revolutionizing the fight against tuberculosis by identifying novel drug resistance genes in Mycobacterium tuberculosis.
Explore how proteomics is revolutionizing our understanding of drug resistance by studying proteins rather than just genes.
Discover how restoring wild-type p53 activity in p53-null HL-60 cells transforms drug-resistant cancer cells into therapy-responsive targets, offering new hope for cancer treatment.
Research on the stepwise evolution of docetaxel resistance in breast cancer cells and emerging strategies to combat it.